Response by Hänggi and Macdonald to letter regarding article, Randomized, open-label, phase 1/2a study to determine the maximum tolerated dose of intraventricular sustained release nimodipine for subarachnoid hemorrhage (Newton [nimodipine microparticles to enhance recovery while reducing toxicity after subarachnoid hemorrhage])
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) Editorial |
| Language: | English |
| Published: |
10 Mar 2017
|
| In: |
Stroke
Year: 2017, Volume: 48, Issue: 4, Pages: e114 |
| ISSN: | 1524-4628 |
| DOI: | 10.1161/STROKEAHA.117.016603 |
| Online Access: | Resolving-System, kostenfrei, Volltext: http://dx.doi.org/10.1161/STROKEAHA.117.016603
|
| Author Notes: | Daniel Hänggi and R. Loch Macdonald |
| Item Description: | Gesehen am 04.10.2018 |
|---|---|
| Physical Description: | Online Resource |
| ISSN: | 1524-4628 |
| DOI: | 10.1161/STROKEAHA.117.016603 |